Skip 
Navigation Link
Medical Disorders
Resources
Basic InformationLookupsLatest News
CDC Updates Zika Guidance for Infant CareHealth Tip: Recognize Symptoms of Latex AllergyExercising With Asthma or AllergiesCan Aspirin Stop Liver Cancer in Hepatitis B Patients?Pollution Tied to 9 Million Deaths Worldwide in 2015Health Tip: Protect Yourself Against Breast CancerSkip Opioid Treatment for Migraine in the ERPPI Use Linked to Increased Risk of Ischemic Stroke, MINew Genes Linked to Restless Legs SyndromeAvoiding Alcohol Helps the Heart Beat Better2 Million Americans May Have Arsenic in Their Well WaterFirefighters Exposed to Carcinogens Through the SkinNewer Blood Thinners May Not Bring Higher Bleeding RiskScoliosis Screenings Can Help Catch Spine Problem EarlyArthritis Can Strike ChildrenHealth Tip: Relieve Ear Pressure While FlyingBlack Children Missing Out on Eczema TreatmentNew Framework Guides Tx Decisions for Atopic DermatitisHealth Tip: Recognizing SepsisAround the World, Too Little Relief for PainNearly 4 in 10 U.S. Adults Now ObeseFDA Panel Supports Gene Therapy for Kids With Rare Eye Disease30-Day Mortality Lower With Female SurgeonsDirect Primary Care May Fill Niche for Uninsured3 Factors That Could Raise Your Risk of Bloodstream InfectionStroke Risk Factors Are RisingTwo Ebola Vaccines Spur Lasting Immune ResponseHormone Therapy May Be OK for Women With MigrainesMigraine MattersMedial Temporal Lobe Surgery Linked to Prevalence of TinnitusHigher Levels of Fungus ID'd in Patients With Crohn'sWhere There's Type 1 Diabetes, Celiac Disease May FollowAntibiotic Use Not Linked to Islet, Celiac Disease AutoimmunitySome U.S. Olympians Got West Nile in Brazil, But Not ZikaPenicillin Misconceptions May Raise Post-Op Infection RiskHate UTIs? One Simple Step Can Cut the RiskIDSA: Retail Meat May Be a Transmission Source for UTIsLonger Anesthesia Duration Tied to More Surgical ComplicationsFirst Test to Detect Zika in Blood Donations ApprovedHealth Tip: Learn Symptoms of Childhood SinusitisLimiting 'Cold Time' Could Make More Organs Available for TransplantHealth Literacy Linked to Length of Stay After Abdominal SurgeryZika Vaccine Works in Early Human TrialHealth Tip: Understanding Loud Noise and Hearing LossAllergy Relief Do's and Don'tsPatient Factors Differ for Surgical, All-Cause ReadmissionComing Soon: A Faster Test for Antibiotics Against UTIs?Antibody Injections in Pregnancy Might Shield Fetus From ZikaHealth Tip: Giving BloodMore U.S. Measles Cases From No Vaccine vs. Imported Disease
Questions and AnswersLinksBook Reviews
Related Topics

Vi-Tetanus Toxoid Conjugate Vaccine Can Prevent Typhoid


HealthDay News
Updated: Sep 29th 2017

new article illustration

FRIDAY, Sept. 29, 2017 (HealthDay News) -- A Vi-tetanus toxoid conjugate vaccine is efficacious for prevention of typhoid fever, according to a study published online Sept. 28 in The Lancet.

Celina Jin, M.B.B.S., from the University of Oxford in the United Kingdom, and colleagues examined the efficacy of a Vi-tetanus toxoid conjugate vaccine using an established human infection model of Salmonella enterica serovar Typhi (S Typhi). Healthy adult volunteers (aged 18 to 60 years) were recruited and randomized in a 1-to-1-to-1 ratio to receive a single dose of Vi-conjugate (Vi-TT; 37 participants), Vi-polysaccharide (Vi-PS; 35 participants), or control meningococcal vaccine (31 participants). Participants orally ingested S Typhi and were assessed with daily blood culture over a two-week period.

The researchers found that 77, 35, and 35 percent of participants in the control, Vi-TT, and Vi-PS groups met the composite criteria for typhoid diagnosis, respectively, giving vaccine efficacies of 54.6 and 52 percent for Vi-TT and Vi-PS. In Vi-TT and Vi-PS participants, seroconversion was 100 and 88.6 percent, respectively; Vi-TT vaccine recipients had significantly higher geometric mean titers detected one month post-vaccination.

"Vi-TT is a highly immunogenic vaccine that significantly reduces typhoid fever cases when assessed using a stringent controlled model of typhoid infection," the authors write. "Vi-TT use has the potential to reduce both the burden of typhoid fever and associated health inequality."

One author disclosed ties to the pharmaceutical industry.

Abstract/Full Text
Editorial